Annual EBITDA
$600.00M$316.70M-34.55%
Summary
- Current Value
- As of today, DXCM annual EBITDA is $600.00M, down -34.55% on
- Historical Performance
- DXCM annual EBITDA is up +58.90% over the past 3 years, and up +181.43% over the past 5 years
- All-Time High Comparison
- DXCM annual EBITDA is currently -34.55% below its historical high of $916.70M set on
- 3-Year Low Comparison
- DXCM annual EBITDA is +6.14% above its 3-year low of $565.30M reached on an earlier date
- Sector Comparison
- DXCM annual EBITDA is higher than 92.72% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $600.00M | -34.5% | +58.9% | +181.4% | +1491.9% | |
| Quarterly EBITDA | $306.10M | +47.7% | +64.0% | +172.1% | +2561.8% | |
| TTM EBITDA | $1.02B | +21.6% | +144.5% | +185.5% | +2494.8% | |
| Price | $71.39 | -19.6% | -34.2% | -30.5% | +1894.1% | |
| PE Ratio | 39.73 | -36.3% | -70.0% | -53.4% | – | |
| Annual Revenue | $4.03B | +11.3% | +64.7% | +173.2% | +10000.0% | |
| Annual EPS | $1.42 | +9.3% | +181.5% | +420.1% | +570.7% | |
| $600.00M | -17.9% | +117.7% | +264.7% | +1419.3% | ||
| Annual Net Income | $576.20M | +6.4% | +165.7% | +469.9% | +1176.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $916.70M | -34.5% | |
| 5Y | $916.70M | -34.5% | |
| All | $916.70M | -34.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $565.30M | N/A | +6.1% |
| 5Y | $376.80M | N/A | +59.2% |
| All | -$74.70M | +903.2% |
EBITDA History
FAQ
What is the current annual EBITDA of DXCM?
As of today, DXCM annual EBITDA is $600.00M
What is 1-year change in DXCM annual EBITDA?
DXCM annual EBITDA is down -34.55% year-over-year
What is 3-year change in DXCM annual EBITDA?
DXCM annual EBITDA is up +58.90% over the past 3 years
How far is DXCM annual EBITDA from its all-time high?
DXCM annual EBITDA is currently -34.55% below its historical high of $916.70M set on December 31, 2023
How does DXCM annual EBITDA rank versus sector peers?
DXCM annual EBITDA is higher than 92.72% of companies in Healthcare sector
When is DXCM next annual earnings release?
The next annual earnings release for DXCM is on
Quarterly EBITDA
$306.10M$30.50M+11.07%
Summary
- Current Value
- As of today, DXCM quarterly EBITDA is $306.10M, up +11.07% on
- Historical Performance
- DXCM quarterly EBITDA is up +47.66% year-over-year, and up +63.95% over the past 3 years
- All-Time High Comparison
- DXCM quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- DXCM quarterly EBITDA is +244.71% above its 3-year low of $88.80M reached on
- Sector Comparison
- DXCM quarterly EBITDA is higher than 94.05% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $306.10M | +11.1% | +47.7% | +64.0% | +172.1% | |
| Annual EBITDA | $600.00M | – | -34.5% | +58.9% | +181.4% | |
| TTM EBITDA | $1.02B | +10.7% | +21.6% | +144.5% | +185.5% | |
| Price | $71.39 | +20.4% | -19.6% | -34.2% | -30.5% | |
| PE Ratio | 39.73 | +20.4% | -36.3% | -70.0% | -53.4% | |
| Quarterly Revenue | $1.21B | +4.5% | +21.6% | +57.1% | +141.4% | |
| Quarterly EPS | $0.70 | +57.2% | +109.9% | +188.1% | +287.8% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| Quarterly Net Income | $283.80M | +57.8% | +110.8% | +180.4% | +293.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $306.10M | at high | |
| 3Y | $306.10M | at high | |
| 5Y | $306.10M | at high | |
| All | $306.10M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $193.70M | +58.0% | |
| 3Y | $88.80M | +244.7% | |
| 5Y | $32.70M | +836.1% | |
| All | -$156.00M | +296.2% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of DXCM?
As of today, DXCM quarterly EBITDA is $306.10M
What is DXCM quarterly EBITDA most recent change?
DXCM quarterly EBITDA was up +11.07% on September 30, 2025
What is 1-year change in DXCM quarterly EBITDA?
DXCM quarterly EBITDA is up +47.66% year-over-year
How far is DXCM quarterly EBITDA from its all-time high?
DXCM quarterly EBITDA is currently at its all-time high
How does DXCM quarterly EBITDA rank versus sector peers?
DXCM quarterly EBITDA is higher than 94.05% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
TTM EBITDA
$1.02B$98.80M+10.70%
Summary
- Current Value
- As of today, DXCM TTM EBITDA is $1.02B, up +10.70% on
- Historical Performance
- DXCM TTM EBITDA is up +21.62% year-over-year, and up +144.46% over the past 3 years
- All-Time High Comparison
- DXCM TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- DXCM TTM EBITDA is +86.82% above its 3-year low of $547.10M reached on an earlier date
- Sector Comparison
- DXCM TTM EBITDA is higher than 93.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.02B | +10.7% | +21.6% | +144.5% | +185.5% | |
| Annual EBITDA | $600.00M | – | -34.5% | +58.9% | +181.4% | |
| Quarterly EBITDA | $306.10M | +11.1% | +47.7% | +64.0% | +172.1% | |
| Price | $71.39 | +20.4% | -19.6% | -34.2% | -30.5% | |
| PE Ratio | 39.73 | +20.4% | -36.3% | -70.0% | -53.4% | |
| TTM Revenue | $4.52B | +5.0% | +14.2% | +61.7% | +148.0% | |
| TTM EPS | $1.80 | +25.8% | +7.7% | +205.3% | +197.8% | |
| $535.20M | -22.1% | -14.8% | +100.9% | +80.2% | ||
| TTM Net Income | $720.70M | +26.1% | +5.9% | +195.3% | +211.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.02B | at high | |
| 3Y | $1.02B | at high | |
| 5Y | $1.02B | at high | |
| All | $1.02B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $817.70M | N/A | +25.0% |
| 3Y | $547.10M | N/A | +86.8% |
| 5Y | $366.60M | N/A | +178.8% |
| All | -$157.20M | +750.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of DXCM?
As of today, DXCM TTM EBITDA is $1.02B
What is DXCM TTM EBITDA most recent change?
DXCM TTM EBITDA was up +10.70% on September 30, 2025
What is 1-year change in DXCM TTM EBITDA?
DXCM TTM EBITDA is up +21.62% year-over-year
How far is DXCM TTM EBITDA from its all-time high?
DXCM TTM EBITDA is currently at its all-time high
How does DXCM TTM EBITDA rank versus sector peers?
DXCM TTM EBITDA is higher than 93.78% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- DXCM Official Website www.dexcom.com/global
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1093557/000109355725000280/0001093557-25-000280-index.htm
- DXCM Profile on Yahoo Finance finance.yahoo.com/quote/DXCM
- DXCM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dxcm